731 filings
Page 32 of 37
UPLOAD
yxtpri tdyrv0
4 Feb 08
Letter from SEC
12:00am
8-K
jswcyawowg178a0s79fx
4 Feb 08
Other Events
12:00am
CORRESP
2cjgysy4s0y7wdp1
1 Feb 08
Correspondence with SEC
12:00am
UPLOAD
vlgtyy
30 Jan 08
Letter from SEC
12:00am
8-K
7r91hpscyj37r4cxvx50
28 Jan 08
Other Events
12:00am
CORRESP
xxm 1spxcskyqk3e
11 Jan 08
Correspondence with SEC
12:00am
CORRESP
mz3ca1g0t38cu645
26 Dec 07
Correspondence with SEC
12:00am
UPLOAD
5kda6m
18 Dec 07
Letter from SEC
12:00am
8-K
x6e8ikkq
30 Nov 07
Acorda Therapeutics Completes Enrollment of Phase 3 Clinical Trial of Fampridine-SR
12:00am
8-K
ebq96s lthlmq6pt5a
6 Nov 07
Acorda Therapeutics Reports Third Quarter 2007 Financial Results
12:00am
8-K
02swqh8f3adul1w72aul
12 Oct 07
Other Events
12:00am
8-K
nh2s0sf7ew70k
11 Sep 07
Other Events
12:00am
8-K
pmu0q671tzzuil
6 Sep 07
Other Events
12:00am
8-K
yidvpbby
7 Aug 07
Acorda Therapeutics Reports Second Quarter 2007 Financial Results
12:00am
8-K
ar3sbt ytjjkjw21
20 Jul 07
Acorda Therapeutics Announces Resignation of Mary Fisher
12:00am
8-K
7xtnk8 sf649o6
6 Jul 07
Acorda Therapeutics Announces Exercise of Option by Underwriters
12:00am